Cegedim SA (LON:0DYQ)
London · Delayed Price · Currency is GBP · Price in EUR 13.15
+1.25 (10.50%)
Feb 12, 2026, 8:22 AM GMT
Cegedim Market Cap
Cegedim has a market cap or net worth of 153.52 million as of February 12, 2026. Its market cap has increased by 9.12% in one year.
Market Cap
153.52M
Enterprise Value
404.74M
Revenue
564.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.15
Market Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 95.61M to 153.52M, an increase of 60.57%. That is a compound annual growth rate of 1.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 157.45M | -3.26% |
| Dec 31, 2025 | 162.75M | 12.57% |
| Dec 31, 2024 | 144.58M | -31.60% |
| Dec 29, 2023 | 211.37M | 19.82% |
| Dec 30, 2022 | 176.41M | -36.57% |
| Dec 31, 2021 | 278.10M | -11.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Tristel | 203.19M |
| Animalcare Group | 194.71M |
| Optima Health | 189.54M |
| Diaceutics | 142.24M |